Emerging Growth Capital Investors offers retail and wholesale investors access to a fund of Australian small cap listed biotechnology and life science companies.
Hedge Funds
China consumption story trumps US trade concerns
This year’s single-best trade was Chinese mid-cap semiconductor and tech stocks, according to UBS O’Connor's Kevin Russell. This illustrates how China’s domestic consumption economy allows it to combat any trade wars with the US.
Hedge Funds
Alternative strategies in the eye of the storm: Sunsuper’s Bruce Tomlinson
While Sunsuper's access to cash and public market meant its alternatives allocations weren't tapped for liquidity to facilitate early release payments, Tomlinson said he could take advantage of some more liquid ‘hedge fund-type’ investments during tumbling markets.
Hedge Funds
Consultants dial up transparency and culture assessment of alternatives
“Everyone loves to hear about culture now,” according to Willis Towers Watson's Sara Rejal, who noted during a panel discussion at the Absolute Returns Conference Digital 2020 conference on Wednesday that funds are interested in a broader due diligence particularly with its hedge fund and alternative strategy partners.
Receive our latest articles, profiles, news and event invitations direct to your inbox.
The leading superannuation, institutional investment and fund management publication in Australia.